本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mineralys Therapeutics, Inc.

28.84
-1.1200-3.74%
成交量:12.02萬
成交額:350.23萬
市值:22.82億
市盈率:-10.07
高:29.97
開:29.96
低:28.54
收:29.96
52周最高:47.65
52周最低:8.24
股本:7,914.00萬
流通股本:5,573.32萬
量比:0.52
換手率:0.22%
股息:- -
股息率:- -
每股收益(TTM):-2.8636
每股收益(LYR):-3.6632
淨資產收益率:-42.14%
總資產收益率:-26.50%
市淨率:3.96
市盈率(LYR):-7.87

資料載入中...

2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]